• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过血管紧张素 II 型 1 受体调节前列腺癌细胞中的雄激素受体表达。

Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells.

机构信息

Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

出版信息

Prostate. 2011 Jun 15;71(9):964-75. doi: 10.1002/pros.21312. Epub 2010 Dec 28.

DOI:10.1002/pros.21312
PMID:21541973
Abstract

BACKGROUND

Although the local renin-angiotensin system (RAS) of the prostate gland is related to cell proliferation and angiogenesis, the detailed mechanism remains unclear. We examined the effects of the angiotensin II type 1 receptor (AT1R) on androgen receptor (AR) expression in prostate cancer cells.

METHODS

AR modulation by AT1R was examined by Western blot analysis, luciferase assay, and Immunocytochemical staining. The influence of AR expression by angiotensin II (Ang-II) and AT1R inhibition using siRNA was determined. Furthermore, using angiotensinogen or AT1R knockout (KO) mice, we performed quantitative real-time PCR to investigate the expression of AR.

RESULTS

Ang-II induced cell proliferation with enhancement of AR, prostate specific antigen (PSA), NF-κB, and c-myc, and the activity of AR and PSA promoter. Cell proliferation of LNCaP transfected with AT1R siRNA was decreased by 75% at 7 days by inhibition of AR, PSA, NF-κB, and c-myc. Immunocytochemical staining confirmed the suppression of AR translocation into the nucleus in AT1R siRNA cells. AT1R KO mice showed a decrease in AR expression in the prostate gland. We also found that the expression level of AT1R could modulate the transcriptional level of AR by affecting NF-κB and c-myc expression.

CONCLUSIONS

Knocking down of the AT1R protein resulted in significant inhibition of cell growth, associated with a marked decrease of AR protein. These results indicate that inhibition of AT1R has the potential to influence AR expression in prostate cells, and is anticipated to contribute to the development of novel therapeutic agents for prostate cancer.

摘要

背景

尽管前列腺局部肾素-血管紧张素系统(RAS)与细胞增殖和血管生成有关,但详细机制尚不清楚。我们研究了血管紧张素 II 型 1 型受体(AT1R)对前列腺癌细胞中雄激素受体(AR)表达的影响。

方法

通过 Western blot 分析、荧光素酶测定和免疫细胞化学染色检测 AT1R 对 AR 的调节作用。用血管紧张素 II(Ang-II)和 siRNA 抑制 AT1R 测定 AR 表达的影响。此外,使用血管紧张素原或 AT1R 敲除(KO)小鼠,通过定量实时 PCR 研究 AR 的表达。

结果

Ang-II 诱导细胞增殖,增强 AR、前列腺特异性抗原(PSA)、NF-κB 和 c-myc 以及 AR 和 PSA 启动子的活性。转染 AT1R siRNA 的 LNCaP 细胞的细胞增殖在 7 天时因 AR、PSA、NF-κB 和 c-myc 的抑制而减少了 75%。免疫细胞化学染色证实 AT1R siRNA 细胞中 AR 向核内易位受到抑制。AT1R KO 小鼠前列腺中 AR 表达减少。我们还发现 AT1R 的表达水平可通过影响 NF-κB 和 c-myc 的表达来调节 AR 的转录水平。

结论

敲低 AT1R 蛋白可显著抑制细胞生长,伴随 AR 蛋白明显减少。这些结果表明,抑制 AT1R 有可能影响前列腺细胞中的 AR 表达,并有望为前列腺癌的新型治疗药物的开发做出贡献。

相似文献

1
Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells.通过血管紧张素 II 型 1 受体调节前列腺癌细胞中的雄激素受体表达。
Prostate. 2011 Jun 15;71(9):964-75. doi: 10.1002/pros.21312. Epub 2010 Dec 28.
2
Angiotensin receptors in hormone-independent prostate cancer cell line DU145: presence of two variants of angiotensin type 1 receptor.激素非依赖性前列腺癌细胞系DU145中的血管紧张素受体:血管紧张素1型受体存在两种变体
Med Sci Monit. 2009 Apr;15(4):BR106-10.
3
Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.从LNCaP细胞系建立雄激素非依赖性人前列腺癌细胞系LN-REC4和LNCaP-SF并对其进行特性分析。
Int J Urol. 2007 Mar;14(3):233-9. doi: 10.1111/j.1442-2042.2007.01532.x.
4
Renin-angiotensin system is an important factor in hormone refractory prostate cancer.肾素-血管紧张素系统是激素难治性前列腺癌的一个重要因素。
Prostate. 2006 Jun 1;66(8):822-30. doi: 10.1002/pros.20407.
5
Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.脱氢表雄酮与睾酮、双氢睾酮及雌二醇对人LNCaP前列腺癌细胞增殖和基因表达的比较作用
Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E573-84. doi: 10.1152/ajpendo.00454.2004. Epub 2004 Nov 9.
6
Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.雷帕霉素靶蛋白复合物 1(mTORC1)调节元件结合蛋白(Rheb)通过调控雄激素受体(AR)转导活性和哺乳动物雷帕霉素靶蛋白(mTOR)-核糖体 S6 激酶(S6K)通路促进前列腺癌细胞增殖。
Prostate. 2010 Jun 1;70(8):866-74. doi: 10.1002/pros.21120.
7
c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.c-Jun增强雄激素受体反式激活与前列腺癌细胞增殖相关。
Oncogene. 2006 Nov 16;25(54):7212-23. doi: 10.1038/sj.onc.1209705. Epub 2006 May 29.
8
Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.功能性血管紧张素II 2型受体抑制LNCaP和PC3前列腺癌细胞系中的生长因子信号传导。
Prostate. 2008 May 1;68(6):651-60. doi: 10.1002/pros.20738.
9
Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells.一种抗氧化剂对人前列腺癌细胞中生存素、Bcl-2和前列腺特异性抗原的抗雄激素样作用。
Cancer Detect Prev. 2005;29(4):389-95. doi: 10.1016/j.cdp.2005.05.001.
10
Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.125I标记的针对雄激素受体的三链形成寡核苷酸对人前列腺癌异种移植瘤生长的抑制作用
Chin Med J (Engl). 2008 Nov 20;121(22):2284-9.

引用本文的文献

1
An Insight into GPCR and G-Proteins as Cancer Drivers.G 蛋白偶联受体(GPCR)和 G 蛋白作为癌症驱动因素的深入了解。
Cells. 2021 Nov 24;10(12):3288. doi: 10.3390/cells10123288.
2
Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and studies of prostate cancer.血管紧张素受体自身抗体作为改变疾病进展的暴露因素:前列腺癌的横断面、纵向及[此处可能遗漏具体研究类型]研究
J Transl Autoimmun. 2019 Dec;2. doi: 10.1016/j.jtauto.2019.100008. Epub 2019 Aug 13.
3
Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications.
前列腺癌中的炎症与核因子κB信号传导:机制与临床意义
Cells. 2018 Aug 29;7(9):122. doi: 10.3390/cells7090122.
4
Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the down-regulation of the androgen receptor.2型血管紧张素II受体激动剂通过下调雄激素受体对前列腺癌发生的化学预防作用
Oncotarget. 2018 Feb 14;9(17):13859-13869. doi: 10.18632/oncotarget.24492. eCollection 2018 Mar 2.
5
Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.用于去势抵抗性前列腺癌化学预防和治疗的生物活性天然产物。
Semin Cancer Biol. 2016 Oct;40-41:160-169. doi: 10.1016/j.semcancer.2016.06.003. Epub 2016 Jun 28.
6
Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer.肾素 - 血管紧张素抑制剂可降低非肌层浸润性膀胱癌患者经尿道膀胱肿瘤切除术后的复发率。
J Urol. 2015 Nov;194(5):1214-9. doi: 10.1016/j.juro.2015.05.104. Epub 2015 Jul 11.
7
Expression and clinical significance of angiotensin II type 1 receptor in human hepatocellular carcinoma.血管紧张素II 1型受体在人肝细胞癌中的表达及临床意义
Exp Ther Med. 2014 Feb;7(2):323-328. doi: 10.3892/etm.2013.1411. Epub 2013 Nov 15.
8
Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts.血管紧张素原启动子多态性可预测美国和西班牙特发性肺纤维化队列中的低弥散量。
Lung. 2013 Aug;191(4):353-60. doi: 10.1007/s00408-013-9476-2. Epub 2013 May 30.
9
Angiotensin receptor blockers and risk of prostate cancer among United States veterans.血管紧张素受体阻滞剂与美国退伍军人前列腺癌风险。
J Clin Pharmacol. 2013 Jul;53(7):773-8. doi: 10.1002/jcph.98. Epub 2013 May 17.
10
Angiotensin and systems thinking: wrapping your mind around the big picture.血管紧张素与系统思维:从整体角度理解全局
Ochsner J. 2013 Spring;13(1):11-25.